BlackRock Inc. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$330,838,512
-19.9%
6,587,784
+0.8%
0.01%
-9.1%
Q2 2023$413,058,452
+38.6%
6,535,735
-1.3%
0.01%
+22.2%
Q1 2023$297,937,413
+8.4%
6,622,303
+5.5%
0.01%0.0%
Q4 2022$274,893,953
-27.5%
6,274,685
+9.0%
0.01%
-30.8%
Q3 2022$379,297,000
+42.2%
5,756,501
+9.0%
0.01%
+44.4%
Q2 2022$266,681,000
-22.4%
5,279,758
-1.9%
0.01%0.0%
Q1 2022$343,876,000
-39.8%
5,383,138
+0.9%
0.01%
-40.0%
Q4 2021$571,632,000
+7.0%
5,336,874
+2.7%
0.02%0.0%
Q3 2021$534,409,000
+17.2%
5,198,014
+0.2%
0.02%
+15.4%
Q2 2021$456,151,000
-6.9%
5,185,918
+2.9%
0.01%
-7.1%
Q1 2021$490,106,000
-13.6%
5,040,686
-0.3%
0.01%
-22.2%
Q4 2020$567,048,000
+27.8%
5,056,163
+5.6%
0.02%
+12.5%
Q3 2020$443,780,000
+15.2%
4,787,270
-3.0%
0.02%
+6.7%
Q2 2020$385,068,000
+40.4%
4,936,789
+5.3%
0.02%
+15.4%
Q1 2020$274,277,000
-19.6%
4,690,069
+10.2%
0.01%0.0%
Q4 2019$341,039,000
+8.0%
4,257,120
-1.0%
0.01%0.0%
Q3 2019$315,818,000
-18.5%
4,298,597
+4.6%
0.01%
-23.5%
Q2 2019$387,621,000
+42.5%
4,109,222
+20.9%
0.02%
+41.7%
Q1 2019$272,096,000
+46.5%
3,399,075
-1.4%
0.01%
+33.3%
Q4 2018$185,772,000
-31.0%
3,445,991
-0.1%
0.01%
-25.0%
Q3 2018$269,241,000
+27.7%
3,449,135
+3.8%
0.01%
+20.0%
Q2 2018$210,876,000
-29.4%
3,321,905
+1.9%
0.01%
-28.6%
Q1 2018$298,808,000
+28.6%
3,258,513
+5.7%
0.01%
+27.3%
Q4 2017$232,401,000
+11.8%
3,081,861
+3.3%
0.01%
+10.0%
Q3 2017$207,845,000
+43.2%
2,983,280
+4.2%
0.01%
+25.0%
Q2 2017$145,131,000
+76.8%
2,864,255
+39.6%
0.01%
+60.0%
Q1 2017$82,078,000
+149132.7%
2,052,435
+103663.1%
0.01%
Q4 2016$55,000
-6.8%
1,978
+0.3%
0.00%
Q3 2016$59,000
+126.9%
1,972
+50.2%
0.00%
Q2 2016$26,000
+136.4%
1,313
+123.7%
0.00%
Q1 2016$11,000
+83.3%
587
+171.8%
0.00%
Q4 2015$6,000
+20.0%
2160.0%0.00%
Q3 2015$5,000
-16.7%
2160.0%0.00%
Q2 2015$6,0002160.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders